• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Amyloid Beta Related Angiitis in the Setting of Anticoagulation (P2.256)
Conclusion: ABRA is a rare, but treatable cause of rapid cognitive decline. Early recognition of such a rare complication of CAA can improve outcomes through offering proper immunosuppressive treatment in a timely manner. The role of amyloid PET scan as a supportive diagnostic tool for CAA and ABRA is still to be defined.Disclosure: Dr. Costa has nothing to disclose. Dr. Albadareen has nothing to disclose. Dr. Sundararajan has nothing to disclose. Dr. Burns has received research support from Janssen, Wyeth, Pfizer, Danone, Baxter, and Lilly/Avid Radiopharmaceuticals.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Costa, C., Albadareen, R., Sundararajan, J., Burns, J. Tags: Cerebrovascular Disease and Interventional Neurology: Genetics and Stroke Source Type: research